Sanofi Adds Firepower in Exiting $13 Billion Regeneron Stake

Published May 26, 2020

Sanofi is selling a stake in Regeneron Pharmaceuticals Inc. valued at about $13 billion, giving the French drugmaker more firepower to potentially snap up promising assets in the cancer, gene therapy and rare-disease fields.

Related Stories